Please use this identifier to cite or link to this item:
|Title:||Endogenous endophthalmitis in a rheumatoid patient on tumor necrosis factor alpha blocker.|
|Authors:||Agarwal, Pankaj Kumar|
|Citation:||Agarwal PK, Gallaghar M, Murphy E, Virdi M. Endogenous endophthalmitis in a rheumatoid patient on tumor necrosis factor alpha blocker. Indian Journal of Ophthalmology. 2007 May-Jun; 55(3): 230-2|
|Abstract:||The development of anti-tumor necrosis factor (TNF) therapies is a milestone in the therapy of rheumatic diseases. It is of concern whether all potential undesired complications of therapy have been evaluated within clinical trials which have led to treatment approval. Specialists prescribing TNF blockers should be aware of the unusual and severe complications that can occur. We describe a case of endogenous endophthalmitis in a rheumatoid patient on TNF alpha blocker.|
|Appears in Collections:||Indian Journal of Ophthalmology|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.